Clinical Trials in Tennessee

Showing 7481-7500 of 20,239 trials

Investigating Biological Markers, Targets, and Intervention for Mood Disorders

NCT04632498

This multi-modal methods study will investigate neurophysiological, endocrinological, cognitive, psycho-social-emotional markers of disease, and targets for integrative health treatments in mood disorders.

Major Depressive DisorderDepressionStress

Vanderbilt University Medical Center61 participantsStarted Oct 2021

Nashville, Tennessee, United States

TERMINATEDNA29 miles

Spiration Valves Against Standard Therapy

NCT02382614

VAST is a multicenter, prospective, randomized, controlled study designed to evaluate treatment of persistent air leak with the SVS as compared to standard chest tube drainage management and other standard-of-care interventions in the control group. Eligible subjects will be randomized to receive either Spiration Valves (investigational arm) or continue standard-of-care treatment (control arm). Once the air leak has resolved, Spiration Valves should be removed.

Pulmonary Air Leaks

Olympus Corporation of the Americas75 participantsStarted May 2015

Fort Smith, Arkansas, United States • Mountain View, California, United States • San Francisco, California, United States +17 more locations

Investigating Biological Markers, Targets, and Intervention for Mood Disorders

Spiration Valves Against Standard Therapy

Find Trials by Condition in Tennessee

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)

Safety Surveillance Cohort Study of Vaccinia Vaccine (ACAM2000®)

Palbociclib (PD-0332991) Combined With Fulvestrant In Hormone Receptor+ HER2-Negative Metastatic Breast Cancer After Endocrine Failure (PALOMA-3)

TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)

Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma

PREDICT Trial: PRospective Evaluation of NTM Disease In CysTic Fibrosis

Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPA

Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies Avalglucosidase Alfa and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease

A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts

Retrospective Evaluation of SuperSaturated Oxygen (SSO2) Therapy Clinical Utility

Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma

An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-2)

Study of AT-02 in Healthy Volunteers and Subjects With Systemic Amyloidosis

Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors

An Open-Label, Single Arm Study of Obinutuzumab Short Duration Infusion in Patients With Previously Untreated Advanced Follicular Lymphoma

A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD

Neoadjuvant and Adjuvant Checkpoint Blockade

A Study of Atezolizumab in Locally Advanced or Metastatic Urothelial or Non-Urothelial Carcinoma of the Urinary Tract